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Responses to Referees comments 
 
We are grateful to the referees for their supportive comments and insightful criticisms. We have 
tried to answer all points raised and make the corrections that are necessary. Changes to the text 
are marked in red. 
 
 
Referee: 1 
 
 
I have some comments and questions for the authors: 
 
Methods -  
1) How many animals were included in each group - stroke + aECM, stroke = cells/aECM, etc? 
 
This is described on page 7, paragraph 3 
 
2) After how long had the stem cells been in culture prior to transplantation?  And how did this time 
point compare to the time points analysed in the vitro assays? 
 
We cultured cells for 24 hours prior to transplantation, similar to the time we cultured the cells for 
prior to beginning differentiation protocols in the in vitro experiments. This information is provided 
top of page 7. 
 
3) The cells were transplanted 2 days after induction of stroke.  Why was this time point used?  
Presumably it was to avoid any acute lesion-induced inhibition, but do the authors have evidence (or 
can they provide references) to suggest that this time point is 'transplant-ready?' 
 
We justify the age of transplantation in the introduction (bottom page 4) and we have strengthened 
this by reference to a successful study in mouse using very similar timepoints for lesioning and 
transplantation. 
 
Results -  
1) Is it possible to show or quantify the difference between MAP2 and DCX as suggested as part of 
Figure 1?  Namely the authors suggest that MAP2 immunoreactivity increases with time ans DCX 
decreases over time.  Is it possible to measure this with fluorescence image intensity levels? 
 
This study is essentially qualitative in nature. We have not been able to find a satisfactory method for 
quantifying our data due to the heterogeneity of the cultures and grafts. 
 
 
2) In the in vivo results 1 week post-grafting, the authors describe Figure 2A as a convoluted thin 
layer of hNCAM+ cells but from the looks of the image, this is a bolus of cells.  I would suggest 
rephrasing this, or perhaps including a higher magnification image to illustrate this point which is not 
clear from the current image. 
 
Although the figure showed the most complex “ribbon arrangement” of grafted cells we think we 
saw, we agree that the image is not in sharp focus. Therefore we have replaced it with a different 
image showing a graft with both a mass of grafted cells and a small ribbon or tube of grafted cells.  
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3) In the final paragraph describing the results of 4 weeks post-grafting, there is a mention of DCX+ 
cells 'extending long processes' in the aECM only transplants.  The authors also observed long 
processes extending in their cultured cells + aECM.  Were any such processes observed even if 
random/inconsistent in the transplant groups? 
 
Yes, and so we have added to the results reported on page 14. 
 
Discussion -  
1) The authors mention in the first paragraph of the discussion that their results suggest a 
considerable proliferation of cells has occurred within their transplants.  Is there Ki67 data to 
confirm this?  Was there any such proliferation seen under 'similar' conditions in the in vitro assays? 
 
There is no Ki67 data, unfortunately. Are supposition is based on the size of the organoids and the 
presence of many PAX6+ cells in the organoids, which is a marker for progenitor cells undergoing 
division, whereas relatively few PAX6+ cells were observed  in vitro. We have extended the first part 
of the discussion slightly (page 15). 
 
 
2) The authors also mention in the first paragraph of the discussion 'In the first environment,....'  
Could the authors describe/define what they mean as their 'first environment?' 
 
We have replaced this phrase with “in vitro”. 
 
3) The authors reference the Horie et al study which showed VEGF expression from their transplants 
stimulated vessel formation.  These transplants were human fetal derived transplants. Is their any 
evidence to suggest that iPSCs secrete VEGF in the literature? 
 
We can find no good evidence that iPSCs secrete VEGF, but did find evidence that neural progenitors 
of the hippocampus do, at least in mice, and we have added this to the discussion on page 18 
 
On of the main components of these experiments was the inclusion of a stroke lesion, however not 
much discussion was made on the injury-effect on the lesion.  Could the authors discuss how the 
lesion affected their transplants?  
 
We haven’t carried out experiments where cells where grafted without a prior ischaemic lesion so I’m 
afraid we can’t discuss this point. 
 
 
Minor points -  
1) Some of the text mentions of the figures were not correct.  Figures 3B, 3C on page 13 are said to 
have DCX and bTub with NCAM however those to images have Pax6 and DCX with NCAM.  No bTub 
is shown in these figures.  
 
We have rewritten this paragraph acknowledging that examples of bTUB/hNCAM double-labelling 
are not shown in the figure. 
 
 Also in the following paragraph on page 13, Fig 4B is referred to have IB4 staining and then later to 
have IBA-1.  This should show as Fig 4A having IB4 staining. 
 
Corrected. 
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2) In the Discussion, when the authors describe their 'in vitro experiment' they state that these cells 
survive for up to 43 days.  Would it be more accurate to say they survive at least 43 days?  It appears 
that in their results these cells are still alive at 43 days which suggests they can survive longer.  Or is 
this incorrect? 
 
This is correct and we have corrected the text accordingly 
 
3) Do the authors know how long the aECM extended the survival of the transplants? This may be a 
key point to include in the discussion regarding the benefits of the aECM. 
 
Unfortunately not. We haven’t studied transplantation of these cells under these conditions without 
the hydrogel media. 
 
 
Referee: 2 
 
Comments to the Author 
This manuscript presents a concise description of a straightforward study. The paper is well written, 
the conclusions are clear and are supported by the data presented. The findings are likely to be of 
interest to readers of the journal. I spotted only a few minor issues with the manuscript, listed 
below. 
 
In Figure 2E, an arrow should be added to indicate the location and direction of the presumed 
migration path of host DCX+ neurons. 
 
This has been done and the figure legend corrected appropriately. 
 
On page 13, paragraph 2, state explicitly that IB4 stains both blood vessels and microglia. 
  
We have done so 
 
On page 14, authors refer to Fig4D to say that DCX+ cells were of host origin, because they are 
hNCAM-, however it’s not clear whether panel 4D shows just DCX or both DCX and hNCAM labelling 
(most likely because hNCAM label has been inadvertently omitted).  
 
All DCX labelled sections where double labelled for hNCAM, so we have added this label. Of course, 
no hNCAM labelled cells are present in this part of the section. 
 
Also in Figure 4D, an arrow or other indicator should be added to show the position where DCX+ 
cells apparently cross the corpus callosum. 
 
This is not apparent in this image, so we have added “not shown” to the text. 
 
In Figure 4E, the SVZ should be indicated. 
 
There is no SVZ in the figure, and the text on page 14 has been changed accordingly. 
 
Also on page 14, it would be helpful to add ‘not shown’ after the reference to synaptophysin staining 
on 10 week grafts. 
 
Done. 
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There’s a typo on page 20 ‘SZV’ 
 
Corrected. 
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Abstract 
 
Human neural stem cells (hNSC) derived from induced pluripotent stem cells can be 
differentiated into neurons that could be used for transplantation to repair brain injury. In 
this study we dispersed such hNSC in a 3-dimensional artificial extracellular matrix (aECM) 
and compared their differentiation in vitro and following grafting into the sensorimotor 
cortex (SMC) of postnatal day (P) 14 rat pups lesioned by localised injection of endothelin-1 
at P12. After 10-43 days of in vitro differentiation, a few cells remained as PAX6+ 
neuroprogenitors but many more resembled post-mitotic neurons expressing doublecortin, 
β-tubulin and MAP2. These cells remained dispersed throughout the ECM, but extended 
long processes for over 50 µm. In vivo, by 1 month post grafting, cells expressing human 
specific markers instead organised into cerebral organoids: columns of tightly packed PAX6 
co-expressing progenitor cells arranged around small tubular lumen in rosettes, with a 
looser network of cells with processes around the outside co-expressing markers of 
immature neurons including doublecortin, and CTIP2 characteristic of corticofugal neurons. 
Host cells also invaded the graft including microglia, astrocytes and endothelial cells forming 
blood vessels. By 10 weeks post-grafting the organoids had disappeared and the aECM had 
started to break down with fewer transplanted cells remaining. In vitro, cerebral organoids 
form in rotating incubators that force oxygen and nutrients to the centre of the structures. 
We have shown that cerebral organoids can form In vivo; intrinsic factors may direct their 
organisation including infiltration by host blood vessels.  
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Introduction 
Stroke in the neonatal period  (which occurs mostly within the first week after delivery)  is a 
leading cause of cerebral palsy (Kirton et al. 2011)  for which a range of early intervention 
approaches are under investigation (Basu, 2014). Stem cell therapy is a compelling current 
approach that is being investigated extensively in neurological disorders; early interventions 
using stem cells could provide support to the infarcted cortex, or perhaps even replace lost 
cortical cells. Interventional experiments for cerebral palsy conducted so far suggest that 
stem cells contribute to repair after early brain injury (Kiasatdolatabadi et al. 2017).  
 
Neural stem cells (NSCs) are multipotent; being able to self-renew but ultimately produce 
neurons, astrocytes, and oligodendrocytes, and potentially replace damaged cells (Jendelová 
et al. 2016). NSCs derived from human induced pluripotent stem cells (hiPSCs) originating 
from human umbilical cord blood  were found to be safe and reliable in interventional 
studies using in vitro and in vivo adult and neonatal models of neurological disorders 
(Bużańska et al. 2002; Jablonska et al. 2010). When hiPSC-derived NSCs are transplanted into 
neonatal rats, they have the ability to survive, migrate, and differentiate into neuronal cells, 
with no signs of tumour formation (Jablonska et al. 2010).  
 
An infarcted brain area is a hostile environment for intracerebrally transplanted stem cells 
often leading to grafted cell death (Bakshi et al. 2005; Bliss et al. 2007) The absence of 
trophic factors in the infarction cavity, a damaged blood brain barrier and the loss of 
extracellular matrix (ECM) proteins due to stroke lead to the accumulation of extracellular 
fluid and leakage of plasma proteins into the infarction cavity (Baeten & Akassoglou. 2011) . 
For these reasons, the use of compatible biomaterials that fill the infarction cavity to provide 
the grafted cells with a stimulatory environment for survival and enhance the efficacy of 
stem cell therapy is a crucial aim in treating stroke (Wang et al. 2014).  
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Recent advances in tissue engineering have shown that hydrogel works as a compatible 
artificial ECM (aECM) and can support transplanted stem cell survival in the infarction cavity 
in adult stroke models (Zhong et al. 2010). In vitro and in vivo neuro-regeneration studies 
have shown that hydrogel can be used as scaffold for the stem cells (Thonhoff et al. 2008; 
Zhong et al. 2010; Burdick & Prestwich, 2011; Bible et al. 2012; Liang et al. 2013). However, 
thus far, stem cell transplantation studies have failed to fill the infarction site or produce a 
well-developed, organised formation of regenerated cerebral cells local to the  lesion in vivo 
due to the accumulation of extracellular fluid and proteins in the post-stroke lesion site 
(Baeten & Akassoglou. 2011).  
 
In this study we explored the potential for early intervention after perinatal stroke in an 
animal model by transplanting hNSCs dispersed in aECM at postnatal day 14 into perinatal 
sensorimotor cortex (SMC) damaged by inducing focal ischemia at P12. We made the lesion 
at P12 because this stage of neurodevelopment of the sensorimotor system most closely 
matches the human at the time of birth (Hagberg et al. 2002; Clowry, 2007; Tucker et al. 
2009; Jablonska et al. 2010; Clowry et al. 2014;). Grafts were carried out soon after the 
lesion because corticospinal innervation early in development is crucial to guiding the 
maturation of the sensorimotor system. Aberrant plasticity, leading to the symptoms of 
cerebral palsy, occurs when there is removal of corticospinal input at this stage ( Clowry, 
2007; Eyre. 2007; Kolb & Gibb. 2007; Basu & Clowry, 2015;). Furthermore, the immune 
system is still immature and less able to mount an immunogenic response to xenogeneic 
transplants in neonate rodents (Englund et al. 2002; Coenen et al. 2005; Jablonska et al. 
2010). A study in a P12 mouse stroke model showed that intrastriatal injection of 
embryonic stem cell derived NSCs at P14 attenuated brain atrophy in the longer term 
(Comi et al. 2008) suggesting that this might be an appropriate age to make the transplant. 
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Our hypothesis was that the grafted hNSCs, protected by the aECM and by the 
underdevelopment of the immune system at this stage of maturation would differentiate 
into neurons and extend axons along the corticospinal tract, which is still developing and not 
completely myelinated at this age (Gorgels. 1990; Fallah & Clowry, 1999) . However, instead, 
the transplanted hNSCs organized into structures resembling cerebral organoids that grow in 
vitro under specific culture conditions (Mariani et al. 2012; Shi et al. 2012; Lancaster et al. 
2013; Mason & Price, 2016). However, this did not happen when hNSCs were grown in 3 
dimensional cultures in hydrogel aECM in vitro. We suggest that vascularization of the graft 
in vivo initially promotes organization and initial survival of the organoids but eventually 
sows the seeds of their destruction by exposing the graft to the host immune system. 
 
 
Methods and materials 
 
Experimental design 
 In vitro differentiation of hNSCs/aECM in a 3D culture was assessed at 10, 14, 17 and 43 
days in vitro (DV) using immunocytochemistry. In parallel to the in vitro experiment, we 
undertook in vivo transplantation of hNSCc/aECM into ischaemic SMC of 12 rats to study the 
survival and integration of the hNSCs and the host tissue response 1, 4 and 10 weeks post 
grafting. Animals in a sham group received only aECM transplantation and were studied 4 
weeks post-grafting. 
 
 
 
NSCs culture 
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Human induced pluripotent stem cell-derived neural stem cells (iPSC-NSCs) were obtained 
and reprogrammed from a male newborn cord blood donor (CD34+) and were purchased 
from Axol Bioscience (Cambridge, UK). The differentiation and the transplantation protocols 
were adopted from those provided by Axol Bioscience (available online 
https://www.axolbio.com ) and modified according to other published methods ( Zhong et 
al. 2010; Liang et al. 2013).  
 
Under a sterilized hood, hiPSCs-NSCs were plated in Neural Plating–XF Medium (Axol 
Bioscience) at high density of 200,000 cells/cm
2
 on a coated 6cm petri dish (Sigma Aldrich, 
Poole, UK) overnight at 37
o
C, 5% CO2. On the following day, when NSCs reached 70-80% of 
confluency, cells were rinsed once with 2 mL/10 cm
2
 culture surface area of Dulbecco’s-PBS 
without calcium or magnesium (Life Technologies, Gibco, the Netherlands) and detached by 
incubating cells for 5 minutes at 37
o
C with 1 mL per 10cm
2
 of Unlock-XF (Axol Bioscience). 
The Unlock-XF solution was then diluted by adding four volumes of pre-warmed, 37
o
C, 
Neural Expansion-XF Medium followed by centrifugation at 200g for 5 minutes at room 
temperature. After centrifuging, the supernatant was aspirated and the cell pellet was re-
suspended with freshly prepared HyStem®-C hydrogel scaffold kit (HYSC020, Sigma Aldrich) 
at 1×10
5
 cells/5 μl hydrogel concentration. The hydrogel components hyaluronan, gelatine 
and cross-linker were mixed at a 2:2:1 molar ratio.  
 
Then, 5 µL of the NSC/aECM complex was plated in each of four micro-inserts (Culture-Insert 
4-Well, Ibidi, Germany) that were placed in a 2-chamber slide (Ibidi) filled with sterilized 
phosphate-buffered saline (PBS) to maintain humidity. The slide was placed in a 100 mL Petri 
dish and incubated at 37
o
C, 5% CO2 for one hour to ensure a successful gelling process. Once 
the appropriate gel texture was achieved, 140 µL of pre-warmed, 37
o
C, Neural Maintenance-
XF Medium with growth factors FGF2 and EGF (Axol Bioscience) was added into each insert 
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and the dish was returned to the warm incubator. On the next day, the medium was 
replaced with fresh, pre-warmed, 37ºC, Neural Maintenance-XF Medium without growth 
factor, and after a further 24 hours only two-thirds of the medium was replaced. Then, half 
of the medium was replaced every two days. 
 
Induction of focal ischemia and stem cell transplantation 
Wistar rats were purchased from Charles River Laboratories and were housed in the 
Newcastle Comparative Biology Centre at Newcastle University. All animal procedures were 
approved and performed in accordance with the Newcastle University Animal Welfare and 
Ethics Review Board and under license from the UK Government Home Office in accordance 
with the UK Animals (Scientific Procedures) Act 1986 and European Union directive 
2010/63EU. All rats shared the same room with the same care routine and light/dark cycle. 
 
Under general anaesthesia induced by inhalation of isoflurane, 400 picomoles in total of 
endothelin-1 (ET-1) (Calbiochem, Nottingham, UK) dissolved in 0.9% sodium chloride was 
injected into the SMC of P12 rat pups at two sites to cause focal ischemia (Soleman et al. 
2010). 1 µL of ET-1 solution was injected at a depth of  1mm at each of the following co-
ordinates: +2.00 mm anterior of bregma and +2.00 mm lateral of the midline, and +0.75 mm 
anterior and +2.00 mm lateral according to the Paxinos and Watson atlas (Paxinos & 
Watson, 1998).  
 
 At P14, hNSCs in aECM was transplanted intracerebrally into the ischemic SMC of 15 rat 
pups. Seven pups in a sham group received aECM only and no NSCs. For each rat, a complex 
of 1 x 10
5 
hNSCs in 2µl aECM was prepared; only two components of the HyStem-C 
(hyaluronan and gelatine) were mixed and added to the NSC cell pellet to begin with while 
the cross-linker was added just before transplantation due to the small time window for 
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gelling. For the hydrogel molar ratio (2:2:1) that we used, gelling time was found to be 12 
minutes after adding the cross linker. The cells were cultured for 24 hours in vitro following 
thawing before transplantation. This was comparable to the time that hNSCs were 
cultured prior to induction of differentiation in in vitro experiments (see above).   
 
Under isoflurane induced anaesthesia, a flap in the skull bones was cut and hinged at the 
midline exposing the right SMC. Using a stereotactic frame with inset and ear bars designed 
for rat pups, hydrogel (with or without cells) was injected by Hamilton syringe into the 
ischaemic SMC at co-ordinates 1.3 mm anterior to bregma and 2 mm lateral of the midline 
and at a depth of 1.8 mm. The complex was loaded into 26 gauge autoclaved Hamilton 
syringes 4 minutes after adding the linker. Immediately, to avoid cells settling at the syringe 
bottom while in liquid form, the needle was lowered after breaking the dura with fine tip 
needle into the ischemic SMC at AP1.3, MD2, and DV1.8 co-ordinates. The gradual injection 
of the 2 µl of hNSCs/aECM continued for 4 minutes at a rate of 0.5 µ/min using an Ultra 
micropump with microcontroller (World Precision Instruments, Sarasota, FL, USA).  The 
needle was kept in its place for an additional minute to prevent back flow and was then 
withdrawn slowly.  The skull and scalp was repaired and the animals allowed to recover 
before returning to their mother’s cage for 24 hours. The animals received a subcutaneous 
injection of analgesic such as buprenorphine if any signs of pain or stress were observed. 
 
Tissue processing and immunofluorescence assessments 
Rats were perfused transcardially with 4% paraformaldehyde (PFA) in phosphate buffered 
saline (PBS; pH 7.4) at 1, 4 and 10 weeks post transplantation. The brains were removed and 
cryoprotected by immersion in PBS containing 30% sucrose at 4
O
C. Parallel sets of 8 coronal 
brain sections (50µm) from fixed brains were collected from the frontal two-thirds of the 
brain (cut using a freezing sliding microtome) as free-floating sections. 
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In vitro cells in 3D culture were fixed at four time points: 10, 14, 17, and 43 after initiation of 
differentiation. NSCs in the micro-inserts were rinsed twice with PBS, and then incubated 
with 4% PFA in PBS for 30 minutes at room temperature with gentle agitation. Brain sections 
were incubated at 4C
O
 overnight for immunohistochemistry and in vitro cells were incubated 
similarly for 2 hours for immunocytochemistry with gentle agitation in a cocktail containing 
PBS, 0.3% Triton X-100) for permeabilization, 3% appropriate blocking serum and primary 
antibody. Some sections were, instead, incubated with biotinylated isolectin B4 (1:1000, 
Vector Laboratories, Peterborough UK ) overnight to identify microglia and endothelial cells 
(Benton et al. 2008; Genade & Lang, 2011). 
 
The sections or cells were then washed and incubated for two hours in the dark with the 
conjugated secondary antibodies from the appropriate hosts: Alexa Fluor 488 and Alexa 
Fluor 594 (diluted 1:200–500; Abcam, Cambridge, UK) or with avidin conjugated with 
fluorescent tags (diluted 1:200, Vector Labs) to visualise lectin staining. Nuclei were 
counterstained with 4',6-diamidino-2-phenylindole (DAPI) (Vectashield, Vector Labs). Details 
for the primary antibodies are listed in Table 1. 
 
Image acquisition  
Double-labelled images of coronal brain sections were captured using the upright 
fluorescent microscope Zeiss AxioImager with an automated stage. To obtain 3D 
fluorescence images of the double-labelled sections, a Nikon A1R confocal microscope was 
used. Inverted light and fluorescent confocal microscopy (Nikon A1R inverted) was used to 
capture images of fluorescent double-labelled cells cultured in vitro. Both Nikon microscopes 
were equipped with a colour digital camera (Nikon, DS-Fi1 2560 x 1920).  Images were 
viewed and produced in NIS-Elements Viewer 4.2.  
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Results 
 
Behaviour of hNSCs in aECM cultured in 3D in vitro. 
Cultures were immunostained for PAX6 (paired box 6, transcription factor; cortical 
neuroprogenitor marker) DCX and bTUB (doublecortin and beta-tubulin; markers for 
immature neuroblasts) MAP2 (microtubule associated protein 2: marker for more mature 
neurons) synaptophysin (identifies synaptic vesicles) and GFAP (glial fibrillary associated 
protein: astrocytic marker). See Table 1 for more details. After 10-14 days of differentiation 
only a few PAX6+ neural progenitor cells remained, but many DCX+ immature neurons were 
present (Fig. 1A, B). The number of  bTUB+ immature neurons increased by 14 days of 
differentiation and these neurons were observed  to have extended long processes through 
the gel that were over 200µm in length (Fig. 1C). Similarly, increasing numbers of MAP2+ 
neurons were observed with time, extending long processes over 50µm in length in the 3D 
culture. Interestingly, anti-synaptophysin immunoreactivity was observed at points of 
contact between cells in culture suggesting early synapse formation (Fig. 1D). 
 
Between 17 and 43 days of differentiation in vitro the proportion of cells expressing DCX 
gradually decreased and the proportion expressing MAP2 increased. MAP2+ neurons 
continued to extend long processes in the direction of other MAP2+ neurons or groups of 
neurons thus appearing to form an interconnected network (Fig 1E). Synaptophysin 
immunoreactivity continued to be detected within the vicinity of cell clusters. Fewer cells 
expressed GFAP than expressed markers for neurons. 
 
Behaviour of hNSCs in artificial ECM grafted in vivo. 
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Two experimental groups were compared; hNSCs/aECM and aECM-only, grafted into the 
SMC of a neonatal rat that had received an ischemic lesion The grafting site was investigated 
by immunohistochemistry on brain sections. In addition to the immunofluorescent stains 
described above, antibodies to human cell markers hNCAM (human neural cell adhesion 
molecule; neurons), STEM121 (cytoplasm) STEM123 (hGFAP, astrocytes and radial glia) as 
well as to CTIP2 (chicken ovalbumin upstream promoter transcription factor-interacting 
protein 2; deep layer cortical neuron marker) and IBA 1 (ionized calcium-binding adapter 
molecule 1; microglia) were employed along with isolectin B4 (IB4) histochemistry to identify 
microglia and blood cells (see Table 1 for more details).  
 
One week post-grafting 
Transplanted hNSCs in the gel scaffold remained as masses or arranged themselves into  
convoluted thin ribbons of  hNCAM+ cells  (Fig. 2A) which appeared similar to an early stage 
of cerebral organoid formation (Qian et al. 2016) . Although we employed hNCAM 
antibodies principally to detect neurons of human origin, human radial glial cells also express 
hNCAM (Mariani et al. 2012). Human grafted cells expressing hNCAM but not PAX6 were 
found at the graft site but also away from the graft in the striatum (Fig. 2B) and corpus 
callosum. In addition Stem123+ presumptive human astrocytes were observed within and 
away from the graft (Fig. 2C).  
 
Host cells were attracted towards the graft, whether or not it initially contained hNSCs. 
GFAP+ / hNCAM- host astrocytes surrounded and extended long processes into the graft 
some appearing to have started to migrate toward the centre (Fig. 2D). Similarly, IB4+ and 
IBA+ amoeboid microglia accumulated at the boundary of the graft and a few IB4+ blood 
vessels invaded the transplant (not shown). Host cells also infiltrated the transplanted gel in 
the aECM-only group. We found that GFAP+ astrocytes surrounded and invaded the gel but 
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with fewer of them having long processes seen from astrocytes invading the hNSCs/aECM 
grafts. Also, a few host DCX immunoreactive neuroblasts migrated from the subventricular 
zone (SVZ) of both lateral ventricles ipsilateral and contralateral to the graft toward both cell 
containing and aECM only grafts. Figure 2E shows DCX+/hNCAM- cells appearing to migrate 
from close to the ventricle towards, and mingling with, hNCAM+ cells of graft origin.  
 
Four weeks post-grafting: cerebral organoid formation. 
In 5 out of 6 animals that received grafts and were examined 4 weeks post-grafting, 
transplanted hNSCs  were seen to form neural tube-like rosettes with a morphology 
resembling cerebral organoids previously described to form in vitro under certain culture 
conditions from  neural stem c lls derived from hiPSC (Lancaster et al. 2013; Mariani et al. 
2012). These aggregations of cells, positive for human cell markers, were contained within 
the host SMC (Figure 3A). The 6th brain examined most likely lost its transplant mechanically 
during brain sectioning. The phenotype of a variety of host cells that infiltrated the xenograft 
was tested by immunofluorescence. Although both STEM121 and hNCAM was highly 
expressed in human cells at the graft site, far fewer human cells were observed away from 
the transplant 4 weeks as compared to one week post grafting (Fig. 3A). 
 
The transplanted hNSCs expressing human stem cell markers were present in large numbers 
and had given rise to both neuroprogenitor cells that were PAX6+/hNCAM+ and post-mitotic 
immature neurons which were DCX+/hNCAM+. Columns of tightly packed neuroprogenitor 
cells uniformly expressing PAX6 formed in rosette structures. These progenitor cells 
surrounded a lumen that resembled the neural tube or ventricle of a developing brain
 
(Figure 3). PAX6+ cells expressed hNCAM at the apical surface only (Fig. 3B) as previously 
described for 3D aggregates formed in vitro (Mariani et al. 2012) .  hNCAM is a cell-adhesion 
molecule (Smith et al. 2017) and may form intercellular junctions holding the structure 
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together. Its expression also indicates that these cells were of transplant origin. No other 
post-mitotic markers for neurons or neuroblasts were expressed by these PAX6+ 
progenitors.  
 
Around this “Progenitor cell layer” (PCL) existed a looser network of heterogeneously 
distributed cells that were positive for the human immature neuron marker hNCAM 
indicating that these cells were of human origin (Fig. 3B). Such hNCAM+ cells co-expressed 
DCX (Fig. 3C) and bTUB (not shown) confirming they were post-mitotic neurons forming a 
“Neural cell layer” (NCL).  Moreover, some cells in the NCL co-expressed CTIP2 (Fig. 3D) 
suggesting some human cells were differentiating towards the phenotype of deep layer 
cortical neurons including corticofugal neurons (Arlotta et al. 2005; Ip et al. 2011) . As was 
observed at 1 week post-grafting, a few of the transplanted cells differentiated into 
astrocytes detected by anti- STEM123 immunohistochemistry and were located in the NCL 
close to the PCL (not shown).  
 
Next we examined some of the host cell phenotypes that infiltrated the graft and the 
cerebral organoid structures. IB4 histochemistry detects both blood vessel endothelial cells 
and reactive microglia. Host blood vessels were uniformly distributed through the 
organoids, including both the NCL and PCL (Fig 4A). Reactive microglia were found around 
the graft but not inside it (Fig 4A). Additionally, anti-IBA1 immunostaining which detected 
both quiescent and active host microglia, revealed a much higher density of IBA1-expressing 
amoeboid microglia around and in the aECM adjacent to the organoids, whereas within the 
cerebral organoid there were fewer microglia and these were closer in morphology to th 
quiescent microglia in the adjacent host tissue (Fig. 4B). Similarly, a dense layer of host cells 
expressing the astrocyte marker GFAP but not human cell markers, were often observed 
nested at the boundary between the organoids and the host cortex. They infiltrated the 
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aECM and extended their long processes toward the centre of the graft with some appearing 
to have started to migrate toward the centre (Fig. 4C). It is noteworthy that host reactive 
astrocytes and immunopositive and activated microglia did not always completely surround 
all the graft boundaries. This suggests that the graft was not totally isolated from the host 
cortex and that trajectories existed for cells to exchange between the graft and host cortex.  
 
Finally, we examined some of the host cell phenotypes that infiltrated the aECM but not the 
cerebral organoid structures. Importantly, we found differences between grafts with and 
without hNSCs incorporated. Host DCX+/hNCAM- neuroblasts were located in the lateral 
adult SVZ of both hemispheres and along a migratory trajectory between the SVZ and the 
graft (Fig. 4D) including DCX positive cells apparently crossing the corpus callosum (not 
shown). The DCX+/ hNCAM- cells surrounded the aECM forming a dense network at the 
inferior boundary (Fig. 4E) which was not far from the adult SVZ. In the presence of grafted 
hNSCs, some of the host cells intermingled with hNCAM+/DCX+ neurons of graft origin; 
some had an elongated cell body and extended long processes that penetrated the aECM 
(Fig. 4E). For aECM only transplants, and in regions of hNSC/aECM grafts devoid of 
organoids, host DCX+ cells extending long processes were also seen along the inferior 
border of the graft but in smaller numbers (not shown). Generally, host cells were much 
more likely to enter the graft if transplanted cells were present, and blood vessels were only 
seem to form in the presence transplanted neural stem cells and their progeny. 
 
Ten weeks post-grafting 
In eight animals examined at 10 weeks post-grafting cerebral organoids were no longer 
observed. At some graft sites the aECM appeared to have disappeared, but at other sites it 
was still possible to observe hNCAM positive cells within the remaining aECM (Fig. 5A) 
occasionally along with some associated anti-synaptophysin immunoreactivity (not shown). 
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DCX+/hNCAM- (Fig. 5A) and PAX6+/hNCAM- host cells still appeared to be migrating from 
the SVZ to the graft site. Few STEM123+ astrocytes of human origin remained at this stage 
compared to one and four weeks post-grafting. Furthermore, reactive microglia 
immunopositive for IBA1 surrounded and infiltrated the graft (Fig. 5B).  
 
 
 
Discussion 
 
 
 
This study has demonstrated that human neural stem cells dispersed, suspended and 
differentiated in a three dimensional gel matrix behave quite differently when the gel 
suspension is grafted into the injured sensorimotor cortex of a rat pup. In vitro the cells 
remain dispersed (but with some aggregation) but mostly lose their stem cell identity and 
differentiate into immature neurons with extended processes. In vivo, the cells, over 4 
weeks, progressively aggregate and self-organise into cerebral organoids first described in 
vitro when cells were grown in specialised rotating incubators. These organoids contain a 
mixture of progenitor cells and post-mitotic neuroblasts arranged in separate 
compartments. The greater complexity of these structures 4 weeks compared to 1 week 
post-grafting, and the continued presence of PAX6+ progenitors in large numbers, suggests 
considerable proliferation of the transplanted cells. 
 
 
In vitro experiment 
 
These experiments confirmed the ability of the hNSCs to survive and differentiate in aECM 
before we proceeded to the grafting experiments. The cells grew well in vitro in this 
medium, surviving for at least 43 days, the limit of our experiment, and undergoing 
differentiation with expression of early neuroblast markers such as DCX being replaced with 
markers of more mature neurons (MAP2). This is agreement with previous studies which 
Page 19 of 42 Journal of Anatomy
For Peer Review Only
16 
 
suggested that a 3D hydrogel makes a good environment for culturing differentiating 
neurons (Zhong et al. 2010; Liang et al. 2013). As early as ten days in culture we observed 
immature neurons with processes extending 50μm in length, and by 14 days these processes 
had extended to over 200 μm, the cells expressed both bTUB and MAP2, and synaptophysin 
immunoreactivity was observed at what appeared to be discrete points of contact between 
cells, as it wasn’t observed in spaces where cells did not aggregate. These findings support 
previous observations that a 3D gel scaffold promotes complex neurite outgrowth with 
synapse formation and upregulation of expression of bTUB and MAP2 (Carlson et al. 2016; 
Lam et al. 2014; Smith et al. 2017). Conventional 2D culture of hNSC results in around a 
quarter of surviving cells retaining PAX6 expression after 1 week, indicating they had 
remained as progenitor cells (Alzu'bi et al. 2017). Here we observed very few PAX6+ cells at 
10-14 days in culture and they mostly co-expressed neuronal markers suggesting they were 
transitioning to neuroblasts. Very few cells expressed GFAP immunoreactivity, a marker for 
older radial glia and astrocytes, supporting previous observations that hydrogel promotes a 
neural fate (Seidlits et al. 2010), unlike other ECM preparations, for instance Matrigel, which 
promote astrocyte formation (Thonhoff et al. 2008). 
 
 
In vivo experiment: Cerebral organoid formation 
 
The most striking result of our in vivo experiment was the gradual formation, over one 
month, of structures resembling cerebral organoids which have previously been grown 
under specialised culture conditions from neural stem cells. The defining feature of such 
organoids is the arrangement of several layers of neural progenitor cells around a central 
lumen in a rosette formation, mimicking the neural tube of the developing brain, 
surrounded in turn by a layer of more loosely arranged post-mitotic neurons (Mariani et al. 
2012; Shi et al. 2012; Lancaster et al. 2013; Mason & Price, 2016). The neural tube begins as 
a single layer of proliferating columnar neuroepithelial cells that eventually gives rise to the 
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entire nervous system. These progenitors first divide symmetrically generating radial glial 
cells that later divide asymmetrically producing daughter progenitors (McConnell, 1995). In 
human, PAX6 is expressed at the earliest stages of neuroectoderm development and is 
required for induction of neural identity (Zhang et al. 2010).  As development precedes, 
PAX6 identifies radial glia that gives rise to dorsal forebrain (Campbell, 2003) and by around 
eight post-conceptional weeks, the wall of the human telencephalon is characterised by a 
ventricular zone packed with PAX6+ progenitor radial glia about 10 cells deep (Bayatti et al. 
2008; Harkin et al. 2016) . This bears a close resemblance in size and gene expression to the 
progenitor cell layer (PCL) we identified in our graft organoids and also seen in cerebral 
organoids grown in vitro (Mariani et al. 2012) . 
 
The neural cell layer in our organoid grafts resembled the sub-ventricular (SVZ) and 
intermediate zone in the developing human neocortex after 8 post-conceptional weeks 
(Bayatti et al. 2008) in that the cells formed a looser network, many extending processes, 
and expressed proteins characteristic of migrating neuroblasts and immature neurons (DCX, 
bTUB and MAP2). Dense, cellular packing characteristic of the cortical plate in the early 
developing human cortex (Bayatti et al. 2008) was not observed; neither were PAX6+ 
progenitor cells present as are found in the human SVZ in particular (Bayatti et al. 2008). 
Cultured cerebral organoids have been reported to have PAX6+ neuroprogenitors more 
loosely associated with the PCL but not fully integrated into the NCL (Shi et al. 2012). We 
also found expression of CTIP2 in neurons of the NCL. This transcription factor is expressed 
by human deep layer cortical neurons soon after their neurogenesis (Ip et al. 2011). This 
demonstrated that the grafts have the capacity to produce corticospinal neurons (Arlotta et 
al. 2005). For cerebral organoids in vitro, after 100 days in culture, it has been reported that 
progenitor cells become depleted and an outer cortical plate-like layer containing CTIP2+ 
neurons expands (Qian et al. 2016). Our grafted cells did not survive long enough for this 
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stage to be reached. Very few grafted cells expressed GFAP,  consistent with the observation 
that neurons are produced before glial cells during corticogenesis (Qian et al. 2000). 
 
Vascularisation of the organoids 
One of the most striking features of the grafts was the development of blood vessels 
visualised by staining with IB4. This is known to bind to endothelial cells and mark newly 
formed blood vessels in developing or injured central nervous system tissue in particular  
(Hughes & Chang-Ling, 2000; Vinores et al. 2003; Benton et al. 2008). Such blood vessels 
were not observed in aECM only grafts suggesting that the presence of cells was a stimulus 
to their growth. That these blood vessels did not express human stem cell markers suggest 
that the endothelial cells were of host origin. Similarly host astrocytes, which may 
participate in angiogenesis (Fruttiger, 2002; Scott et al. 2010) were seen to extend processes 
into the graft. This angiogenesis could have happened due to a limited development of scar 
tissue at the infarction site because of the use of hydrogel. Some studies using hydrogels, 
including the one used here, as a vehicle for in vivo transplantation have not stimulated 
angiogenesis (Zhong et al. 2010; Bible et al. 2012) however other researchers have reported 
that hydrogels enhanced vascularization of the graft site (Ju et al. 2014) particularly if they 
are loaded with cytokines (Peattie et al. 2004). A study has reported that grafted stem cells 
secrete a vascular endothelial growth factor (VEGF) that stimulates vessel formation (Horie 
et al. 2011). Neural progenitors of the rodent adult hippocampus also secrete large, 
biologically relevant quantities of VEGF (Kirby et al. 2015). 
 
Therefore, in our experiments it may be that the presence of neural stem cells stimulated 
vascularisation of the graft.  In vitro, a spinning culture vessel is required to promote 
organoid survival, by forcing the oxygen and the fluid to reach the centre of the organoids 
physically (Lancaster et al. 2013; Qian et al. 2016). However, our in vivo experiment it 
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appears that the cerebral organoids overcame the limitation in oxygen and nutrient supply 
by permitting ingrowth of vessels from the host tissue. Angiogenesis, in our experiments, 
may have provided a natural alternative to the rotating vessels for the in vitro organoids to 
keep them nourished. Furthermore, in vitro, in human cerebral organoids it takes 4 weeks 
for neurons and 10 weeks for cortex like structures to appear (Lancaster et al. 2013; Mason 
& Price. 2016). In our grafted organoids, it appears that this time course is accelerated such 
that neurons appear within a week and cortex like structures within 4 weeks. Thus it appears 
that the host in some way provides an extra stimulus to the hNSCs to self-organise and begin 
asymmetric division to produce neurons compared to in vitro organoid cultures. Again 
perhaps this stimulus comes from vascularisation.  
 
Inflammatory response to grafting 
Another host cell type to interact with the graft were microglia. Reactive microglia 
accumulated at the boundary of the graft and invaded aECM only grafts as well as gel only 
parts of cellular grafts. However only quiescent host microglia were found intermingled with 
the organoid structures after 4 weeks post-grafting. It has been suggested that 
encapsulating neural stem cells in hydrogel protects them against an inflammatory reaction 
when grafted to the adult rodent brain (Zhong et al. 2010). Our observations suggest that it 
is the grafted cells themselves that have anti-inflammatory properties rather than the aECM, 
at least during the first four weeks. 
 
The survival rate of the transplanted cells was similar to a previous study in rodent neonate 
lesioned brain in which grafted human cells (with no aECM) survived for five weeks before 
they diminished (Glezer et al. 2007; Jablonska et al. 2010; Kulbatski. 2010) . We did not use 
immunosuppression as some studies have argued that this can prevent neural repair, or lead 
to deterioration in the underlying disorder and prevent the beneficial role of microglia in the 
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repair of the lesioned brain tissue (Glezer et al. 2007; Kulbatski. 2010) . However, the 
vascularisation of our grafts may have exposed them to a more vigorous immune reaction 
with time and contributed to the degradation of the grafts. Another factor in the breakdown 
of the grafts is the fast degradability of the thiolated hydrogel used in our aECM (Hahn et al. 
2007; Prestwich et al. 2012) with the transplanted cells themselves, or the host infiltrating 
cells, potentially contributing to hydrogel dissolution. Moshayedi et al (2016) reported that 
grafted hydrogel degraded faster when mixed with neural stem cells than when grafted 
alone in vivo. 
 
Endogenous repair in response to the graft 
In our study host neuroblasts and neural progenitors were located in the SVZ of the lateral 
ventricles in both hemispheres and along a migratory pathway between the SVZ and the 
xenograft in the ipsilateral hemisphere at all three time points. It has been previously shown 
that after a lesion to the rodent sensorimotor cortex, neurogenesis took place in the SVZ 
and there was migration of new cells to the lesion site guided by blood vessels and reactive 
astrocytes (Saha et al. 2013) although most of these cells eventually differentiate into glia 
rather than neurons. In our study, the host DCX+ neurons were being produced, migrating 
and surviving up to ten weeks following the lesion/graft. Four weeks post-grafting, we found 
that the host neural progenitors and immature neurons surrounded the graft and 
intermingled with the human grafted neurons at the periphery, but not the centre of, the 
cerebral organoids. By 10 PCW, host neuroblasts and grafted human neurons were still 
intermingled at the margins of the graft site. In a similar study that transplanted hydrogel 
encapsulated NSCs in focal ischemic stroke model, the host neuroblasts migrated to the 
graft two weeks after transplantation whether the grafted cells had been injected with or 
without hydrogel (Zhong et al. 2010). Our experiments suggest that the presence of grafted 
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cells increases the migration of host neuroblasts to the graft site, and in particular, the 
invasion of aECM by host neuroblasts. 
 
Conclusion 
By suspending transplanted cells in an aECM prior to grafting, the intention was to provide a 
protective environment that would stimulate the neural stem cells to stop dividing and 
differentiate, producing cortical neurons that could grow axons out of the graft site, or even 
migrate out of the graft site, and also receive connections from the host tissue. Surprisingly, 
instead, this environment permitted self-organisation of the grafted cells into structures 
resembling cerebral organoids observed in culture, including many neural progenitor cells 
that retained a proliferative state in an artificial “ventricular zone”. Neurons were also 
produced and showed some limited evidence of integration with host circuitry over the time 
period examined. 
 
The signal to undergo this transformation could be intrinsic or from the host. Combination of 
hNSCs with aECM alone is not enough as we did not observe this in three dimensional in 
vitro cultures. It seems that the medium term survival of the organoids is dependent 
invasion of the graft by host cells, in particular blood vessels and astrocytes, but the extent 
to which host derived morphogens and growth factors drive this process remains to be 
explored. Some adjustments to the grafting procedure will be required in order to achieve 
the original aims of the experiment. Extended immunosuppression, along with neurostatin 
treatment to supress microglial activation (Gomez-Nicola et al. 2010) may help maintain the 
organoids until they reach the point where neuroproliferation declines and larger numbers 
of neurons are produced. Alternatively other approaches, for instance using a cocktail of 
recently discovered small molecules that halt proliferation and induce cortical neuronal 
differentiation (Qi et al. 2017) might be employed.  
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Figure legends 
 
Figure1 
 
iPSC derived hNSCs differentiated in vitro. All sections are counterstained with the nuclear 
marker, DAPI (blue). A shows that by 10 days in culture (D10) cells had begun to express the 
post-mitotic marker DCX. By D14 a mixture of cells expressed the nuclear neural stem cell 
marker PAX6 (red), the cytoplasmic neuronal marker bTUB (green) or both (B). At D14 bTUB 
expressing cells extended long processes in this 3 dimensional culture medium (C). As early 
as D14, immunoreactivity for the synaptic marker synaptophysin was seen at potential 
points of contact between cultured neurons (D). By D43, an increased number of cells were 
immunoreactive for MAP2 (red), a marker of more mature neurons than bTUB. 
 
Scale bar = 40 µm.  
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Figure 2 
 
One week post grafting:  A shows a graft of artificial ECM (aECM) containing hNCAM+ cells 
(green) positioned deep to the host sensorimotor cortex (SMC) close to the lateral 
ventricle (LV). Some of the hNCAM positive cells were in a disorganized mass (asterisk) 
whereas some had organised themselves into a convoluted ribbon or tube (arrow). B 
shows a group of hNCAM+ cells that have migrated away from the graft into the nearby 
striatum. Grafted cells also expressed hGFAP (C) and could be seen around the edges of the 
graft at the interface with host tissue. D illustrates how host astrocytes (GFAP+, red) 
infiltrated the grafts (asterisks) mingling with hNCAM+ grafted cells (green) in the aECM. 
Also, grafted cells infiltrated th  host tissue (arrows). E shows how host DCX+ cells (red) 
presumably newborn neuroblasts, migrated towards and mingled with hNCAM+ grafted cells 
(green). The arrow indicates the direction of migration.  Blue staining in C and E is the 
nuclear stain DAPI.  
 
Scale bars. A, C, D = 200 µm; B = 50 µm; E = 30 µm.  
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Figure 3 
 
Four weeks post grafting: A shows a graft containing cells positive for the human stem cell 
marker STEM123 (green) within the host sensorimotor cortex (SMC) dorsal to the subcortical 
white matter (WM), lateral ventricle (LV) and striatum (Str) all positive for GFAP (red). 
Grafted cells are arranged in rosettes with high expression of STEM121 in cells close to the 
centre of the rosettes and in the looser arrangement of grafted cells surrounding the 
rosettes. Host astrocytes (red) have invaded the graft, particularly at the margins. B 
demonstrates that there was a dense packed layer of progenitor cells (PCL) expressing PAX6 
(red) and hNCAM (green). The hNCAM was more strongly expressed in cells at the inner, 
luminal surface of the PCL (B, C, D). hNCAM was strongly expressed in the more loosely 
packed layer of post-mitotic neurons (NCL, B). C These neurons also co-expressed DCX and 
hNCAM (yellow) and some co-expressed CTIP2 (nuclear, red) with hNCAM (green) as shown 
in D.  
 
Scale bars. A= B = 200 µm; C = 100 µm; D = 50 µm.  
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Figure 4 
 
Four weeks post grafting: A shows staining with isolectin B4 (IB4, red)) to reveal blood 
vessels penetrated the organoid graft (arrow) and reactive microglia accumulated around 
the margins of the graft for instance (e.g. asterisk) close to the corpus callosum (CC). B 
demonstrates IBA 1 immunoreactivity (green) marking microglia. Reactive microglia 
accumulated in cell free parts of the artificial ECM (aECM) whereas microglia with in the 
organoid (org) appeared more like the quiescent microglia of the host sensorimotor cortex 
(SMC). C Host astrocytic processes (GFAP+, red) penetrated the graft. D Host neuroblasts 
positive for DCX (red) migrated from around the lateral ventricle (LV) towards the graft 
(arrow). E  Host DCX+ neurons (red) mingled with graft derived hNCAM+ cells (green). Nuclei 
are counterstained with DAPI (blue) in A and B. 
 
Scale bars: A, C, D = 200 µm; B,E = 100 µm. 
 
 
 
 
 
 
Figure 5 
 
 10 weeks post grafting: A shows a lesion cavity no longer filled with aECM. What does 
remain is infiltrated with DCX+ host neuroblasts (red) mingled with hNCAM+ transplanted 
cells, some of which are at the interface with the host tissue (arrow). B Reactive microglia 
positive for IBA1 (green) accumulated around the remants of the graft.  
 
Scale bars = 100 µm. 
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Table 1; primary antibodies used in this study.  
 
Primary Antibody to Supplier Description of 
target 
Antibody 
dilution 
Reference RRID number 
IHC ICC 
IBA1, ionized calcium-
binding adapter molecule 
1 (gt polyclonal) 
Abcam, 
Cambridge, 
UK. 
microglia 1:500 - Ito et al. 
(1998) 
AB_2224402 
 
GFAP, glial fibrillary 
acidic protein(ms 
monoclonal) 
Sigma-
Aldrich, 
Poole, UK. 
astrocytes  1:1000 1:200 Burtrum & 
Silverstein 
(1994) 
AB_477010 
Pax6, paired box protein  
(rb polyclonal)  
Cambridge 
Bioscience, 
Cambridge, 
UK 
 
Proliferating 
cortical 
progenitor 
cells including 
radial glia 
1:500 1:100 Bayatti et 
al. (2008) 
AB_2565003 
 
hNCAM, neural cell 
adhesion molecules  
(ms monoclonal IgG)) 
Santa Cruz 
Biotechnology 
Heidelberg, 
Germany. 
Human 
neural cell 
membranes 
1:1000 1:100 Smith et al. 
(2017) 
AB_627128 
 
STEM121  
(ms monoclonal) 
Stem Cells 
Inc., 
Cambridge, 
UK 
human cell 
cytoplasm  
1:3000 1:500 Guzman et 
al. (2007); 
Sareen et 
al. (2014); 
Tornero et 
al. (2013) 
AB_2632385 
 
STEM123 (ms 
monoclonal) 
Stem Cells, 
Inc.  
hGFAP, 
human  
astrocytes and 
radial glial 
cells 
1:2000 1:250 Sareen et 
al. (2014) 
 
DCX, doublecortin  
(rb polyclonal) 
Abcam Migrating 
neuroblasts  
1:1000 1:250 Lam et al. 
(2014) 
AB_2088478 
 
Map2, 
Microtubule Associated 
Protein-2 (rb polyclonal) 
 
Abcam Neuron-
specific 
expression in 
dendrites and 
soma. 
1:500 1:200 Guzman et 
al. (2007) 
AB_448205 
 
Synaptophysin Sigma-Aldrich  Synaptic 
vesicle marker 
1:5000 1:200 Smith et al. 
(2017) 
AB_477523 
 
CTIP2, COUP-TF-
interacting protein 2  
 (rb polyclonal) 
Abcam Transcription 
factor marking 
corticofugal 
neurons 
1:300 - Ip et al 
(2011) 
AB-1140055 
TUJ1, Beta-III-Tubulin (ms 
polyclonal) 
Merck 
Millipore 
Watford, UK. 
specific class 
III β-tubulin  
post-mitotic 
neuroblasts 
and neurons 
1:500 1:100 Stevanato 
et al. 
(2015) 
AB_570918 
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Figure1  
 
iPSC derived hNSCs differentiated in vitro. All sections are counterstained with the nuclear marker, DAPI 
(blue). A shows that by 10 days in culture (D10) cells had begun to express the post-mitotic marker DCX. 
By D14 a mixture of cells expressed the nuclear neural stem cell marker PAX6 (red), the cytoplasmic 
neuronal marker bTUB (green) or both (B). At D14 bTUB expressing cells extended long processes in this 3 
dimensional culture medium (C). As early as D14, immunoreactivity for the synaptic marker synaptophysin 
was seen at potential points of contact between cultured neurons (D). By D43, an increased number of cells 
were immunoreactive for MAP2 (red), a marker of more mature neurons than bTUB.  
 
Scale bar = 40 µm.  
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One week post grafting:  A shows a graft of artificial ECM (aECM) containing hNCAM+ cells (green) 
positioned deep to the host sensorimotor cortex (SMC) close to the lateral ventricle (LV). Some of the 
hNCAM positive cells were in a disorganized mass (asterisk) whereas some had organised themselves into a 
convoluted ribbon or tube (arrow). B shows a group of hNCAM+ cells that have migrated away from the 
graft into the nearby striatum. Grafted cells also expressed hGFAP (C) and could be seen around the edges 
of the graft at the interface with host tissue. D illustrates how host astrocytes (GFAP+, red) infiltrated the 
grafts (asterisks) mingling with hNCAM+ grafted cells (green) in the aECM. Also, grafted cells infiltrated the 
host tissue (arrows). E shows how host DCX+ cells (red) presumably newborn neuroblasts, migrated 
towards and mingled with hNCAM+ grafted cells (green). The arrow indicates the direction of 
migration.  Blue staining in C and E is the nuclear stain DAPI.  
 
Scale bars. A, C, D = 200 µm; B = 50 µm; E = 30 µm.  
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Figure 3  
 
Four weeks post grafting: A shows a graft containing cells positive for the human stem cell marker STEM123 
(green) within the host sensorimotor cortex (SMC) dorsal to the subcortical white matter (WM), lateral 
ventricle (LV) and striatum (Str) all positive for GFAP (red). Grafted cells are arranged in rosettes with high 
expression of STEM121 in cells close to the centre of the rosettes and in the looser arrangement of grafted 
cells surrounding the rosettes. Host astrocytes (red) have invaded the graft, particularly at the margins. B 
demonstrates that there was a dense packed layer of progenitor cells (PCL) expressing PAX6 (red) and 
hNCAM (green). The hNCAM was more strongly expressed in cells at the inner, luminal surface of the PCL 
(B, C, D). hNCAM was strongly expressed in the more loosely packed layer of post-mitotic neurons (NCL, B). 
C These neurons also co-expressed DCX and hNCAM (yellow) and some co-expressed CTIP2 (nuclear, red) 
with hNCAM (green) as shown in D.  
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Figure 4  
 
Four weeks post grafting: A shows staining with isolectin B4 (IB4, red)) to reveal blood vessels penetrated 
the organoid graft (arrow) and reactive microglia accumulated around the margins of the graft for instance 
(e.g. asterisk) close to the corpus callosum (CC). B demonstrates IBA 1 immunoreactivity (green) marking 
microglia. Reactive microglia accumulated in cell free parts of the artificial ECM (aECM) whereas microglia 
with in the organoid (org) appeared more like the quiescent microglia of the host sensorimotor cortex 
(SMC). C Host astrocytic processes (GFAP+, red) penetrated the graft. D Host neuroblasts positive for DCX 
(red) migrated from around the lateral ventricle (LV) towards the graft (arrow). E  Host DCX+ neurons (red) 
mingled with graft derived hNCAM+ cells (green). Nuclei are counterstained with DAPI (blue) in A and B.  
 
Scale bars: A, C, D = 200 µm; B,E = 100 µm.  
 
 
175x184mm (300 x 300 DPI)  
 
 
Page 42 of 42Journal of Anatomy
For Peer Review Only
  
 
 
Figure 5  
 
10 weeks post grafting: A shows a lesion cavity no longer filled with aECM. What does remain is infiltrated 
with DCX+ host neuroblasts (red) mingled with hNCAM+ transplanted cells, some of which are at the 
interface with the host tissue (arrow). B Reactive microglia positive for IBA1 (green) accumulated around 
the remants of the graft.  
 
Scale bars = 100 µm.  
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